
Please try another search
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Name | Age | Since | Title |
---|---|---|---|
David Owens | 63 | 2017 | Chief Medical Officer, Member of Scientific Advisory Board & Director |
Benjamin V. Hu | 67 | 2022 | Independent Director |
Mark White | 63 | 2018 | President, CEO, CFO & Director |
Abraham Scheer | - | - | Member of Medical Advisory Board & Member of Scientific Advisory Board |
Alan Kazden | 64 | 2019 | Independent Director |
Leslie Bernhard | 81 | 2023 | Independent Chairperson of the Board |
Leonard A. Osser | 78 | - | Member of Strategic Advisory Board |
Gian Domenico Trombetta | 64 | - | Member of Strategic Advisory Board |
Tucker Andersen | - | - | Member of Strategic Advisory Board |
Mingxiong Huang | - | 2025 | Member of Scientific Advisory Board |
Robert Rothstein | - | 2025 | Member of Scientific Advisory Board |
Gina Robins | - | 2025 | Member of Strategic Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review